MedPath

A study on Neeradaipu Ennai in the management of Prosthakola Veekkam (Benign Prostatic Hyperplasia)

Phase 2
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2023/08/056452
Lead Sponsor
ational Institute of siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.International Prostate Symptom Score(IPSS) >12 at screening

2.Post void residual urine volume less than or equal to 350 ml (By USG)

3.Increased Prostate gland size (Normal size-3x4x2cm)

Exclusion Criteria

1.K/C/O CA prostate

2.K/C/O Urinary bladder calculus

3.K/C/O Acute and chronic renal failure

4.K/C/O Stricture urethra

5.K/C/O PSA more than 4ng/ml

6.Patients with prior history of prostatic/urethral surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in International Prostate Symptom Score(IPSS) will be <br/ ><br>assessed before & after treatmentTimepoint: 18 MONTHS
Secondary Outcome Measures
NameTimeMethod
1.Reduction in prostate gland size & residual urine volume will be assessed <br/ ><br>using ultrasound abdomen scan before and after treatment. <br/ ><br>2.Changes in Quality of life will be assessed using BPH Specific Quality of <br/ ><br>Life Scale before and after treatmentTimepoint: 18 MONTHS
© Copyright 2025. All Rights Reserved by MedPath